NCT02349126 - Study of ARC-520 in Patient With Chronic Hepatitis B Virus | Biotech Hunter

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions

Chronic Hepatitis B

Interventions

DRUG

ARC-520 Injection

ARC-520 Injection is a liver-targeted antiviral therapeutic designed to treat chronic hepatitis B virus (HBV) infection via an RNA interference (RNAi) mechanism.

Trial Locations (1)

3004

Nucleus Network Ltd, Melbourne